20221027104337.jpg&width=320&height=100)
Newswise — Nearly 50 presentations by researchers and clinicians from Yale Cancer Center (YCC) at Yale School of Medicine will be among the more than 5,000 abstracts available during the annual meeting of the American Society of Clinical Oncology (ASCO) May 31 to June 4 in Chicago, Ill.
This year's meeting, themed “The Art and Science of Cancer Care: From Comfort to Cure” will include over 200 sessions. The 48 YCC presentations will include phase II trial results for a cancer vaccine in combination with an immunotherapy drug, a new tool to predict the risk of recurrence of hormone receptor-positive, HER2-negative breast cancer, and the factors affecting sexual function of young women with breast cancer.
YCC experts will deliver 10 oral presentations and 38 poster presentations. They include:
Poster Session
June 1; 9:00AM CDT
Presenter and Senior Author:
Poster Session
June 1; 1:30PM CDT
Presenter:
Oral Abstract
June 1; 4:24PM CDT
Presenter:
Oral Abstract
June 2; 10:24AM CDT
Presenter and Senior Author:
Oral Abstract
June 3; 1:27PM CDT
Presenter:
Poster Session
June 3; 1:30PM CDT
Presenter:
Poster Session
June 3; 1:30PM CDT
Presenter and Senior Author:
Oral Abstract
June 3; 5:24PM CDT
Presenter:
Click here to see the of YCC presentations.
Yale Cancer Center combines a tradition of innovative cancer treatment and quality care for our patients. A National Cancer Institute (NCI) designated comprehensive cancer center since 1974, Yale Cancer Center is one of only 56 such centers in the nation and the only one in Connecticut. Yale Cancer Center members include national and internationally renowned scientists and physicians at Yale School of Medicine and Smilow Cancer Hospital. This partnership enables the Center to provide the best approaches for prevention, detection, diagnosis, and treatment for cancer.鈥�
Media Contact:
Michael Masciadrelli [email protected]
MEDIA CONTACT
Register for reporter access to contact detailsRELATED EXPERTS
Michael Cecchini
Associate Professor of Medicine; Co-Director, Colorectal Program in the Center for Gastrointestinal Cancers
Yale Cancer Center/Smilow Cancer HospitalBarbara Burtness
Professor of Medicine (Medical Oncology); Chief Translational Research Officer, Yale Cancer Center; Chief, Head and Neck Cancers/Sarcoma; Co-Leader, Developmental Therapeutics, Yale Cancer Center
Yale Cancer Center/Smilow Cancer HospitalPatricia LoRusso
Professor of Medicine (Medical Oncology); Chief, Experimental Therapeutics; Associate Cancer Center Director, Experimental Therapeutics
Yale Cancer Center/Smilow Cancer HospitalPamela Kunz
Associate Professor of Internal Medicine (Medical Oncology); Director, Center for Gastrointestinal Cancers at Smilow Cancer Hospital and Yale Cancer Center; Chief, GI Medical Oncology; Vice Chief, Diversity, Equity, and Inclusion, Medical Oncology
Yale Cancer Center/Smilow Cancer HospitalRoy Herbst
Ensign Professor of Medicine (Medical Oncology) and Professor of Pharmacology; Deputy Director, Yale Cancer Center; Chief of Medical Oncology, Yale Cancer Center and Smilow Cancer Hospital; Assistant Dean for Translational Research, Yale School of Medicine; Director, Center for Thoracic Cancers, Yale Cancer Center and Smilow Cancer Hospital; Co-Principal Investigator and Community Outreach Co-Leader, Cancer Disparities Firewall Project
Yale Cancer Center/Smilow Cancer HospitalEric Winer
Yale Cancer Center Director; Smilow Cancer Hospital President & Physician-in-Chief
Yale Cancer Center/Smilow Cancer Hospital
RSS